Genmab A/S (GNMSF) Current Assets (2018 - 2026)
Genmab A's (GNMSF) quarterly Current Assets came in at $2.6 billion in Q1 2026, down 36.26% YoY from $4.0 billion in Q1 2025, and down 10.81% on a QoQ basis from $2.9 billion in Q4 2025.
Genmab A/S (GNMSF) Current Assets (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 7 years of Current Assets data on file, last reported at $2.6 billion in Q1 2026.
- Quarterly Current Assets fell 36.26% year-over-year to $2.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (down 36.26% YoY) and the FY2025 annual result came in at $2.9 billion, down 26.03% from the prior year.
- Current Assets retreated to $2.6 billion in Q1 2026, from $2.9 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $4.9 billion in Q4 2023 to a low of -$2.4 billion in Q3 2024.
- A 4-year average of $2.7 billion and a median of $3.9 billion in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2025 — Current Assets soared 1305.07% — and 2026, when it sank 36.26%.
- Tracing GNMSF's Current Assets over 4 years: stood at $4.9 billion in 2023, then slipped by 20.6% to $3.9 billion in 2024, then dropped by 26.03% to $2.9 billion in 2025, then declined by 10.81% to $2.6 billion in 2026.
- The last three Current Assets figures came in at $2.6 billion (Q1 2026), $2.9 billion (Q4 2025), and $4.5 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Bn |
| Mar 31, 2026 | 2.57 Bn |
| Dec 31, 2025 | 2.89 Bn |
| Sep 30, 2025 | 4.47 Bn |
| Jun 30, 2025 | 3.91 Bn |
| Mar 31, 2025 | 4.04 Bn |
| Dec 31, 2024 | 3.90 Bn |
| Sep 30, 2024 | -2.40 Bn |
| Mar 31, 2024 | -335.00 Mn |
| Dec 31, 2023 | 4.91 Bn |
| Sep 30, 2020 | 19,504.00 |
| Dec 31, 2019 | 13,961.00 |
| Sep 30, 2019 | 12.26 Bn |
| Dec 31, 2018 | -831.75 Mn |